skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 72  for All Library Resources

Results 1 2 3 4 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis
Material Type:
Article
Add to My Research

Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis

Neurology : neuroimmunology & neuroinflammation, 2024-05, Vol.11 (3), p.e200228-e200228 [Peer Reviewed Journal]

EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200228 ;PMID: 38603771

Full text available

2
Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia
Material Type:
Article
Add to My Research

Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia

Neurology : neuroimmunology & neuroinflammation, 2023-09, Vol.10 (5) [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200137 ;PMID: 37311646

Full text available

3
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
Material Type:
Article
Add to My Research

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder

Neurology : neuroimmunology & neuroinflammation, 2024-01, Vol.11 (1), p.e200188-e200188 [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200188 ;PMID: 38134369

Full text available

4
CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity
Material Type:
Article
Add to My Research

CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity

Neurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200200-e200200 [Peer Reviewed Journal]

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200200 ;PMID: 38346270

Full text available

5
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria
Material Type:
Article
Add to My Research

Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria

Neurology : neuroimmunology & neuroinflammation, 2024-01, Vol.11 (1) [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200183 ;PMID: 37977848

Full text available

6
Late-Onset Anti-GABA B Receptor Encephalitis: Clinical Characteristics and Outcomes Differing From Early-Onset Patients
Material Type:
Article
Add to My Research

Late-Onset Anti-GABA B Receptor Encephalitis: Clinical Characteristics and Outcomes Differing From Early-Onset Patients

Neurology : neuroimmunology & neuroinflammation, 2023-07, Vol.10 (4) [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200131 ;PMID: 37230544

Full text available

7
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
Material Type:
Article
Add to My Research

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

Neurology : neuroimmunology & neuroinflammation, 2022-01, Vol.9 (1) [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000001105 ;PMID: 34753829

Full text available

8
Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment
Material Type:
Article
Add to My Research

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment

Neurology : neuroimmunology & neuroinflammation, 2020-05, Vol.7 (3), p.e696-e696 [Peer Reviewed Journal]

2020 American Academy of Neurology ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2020 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000000696 ;PMID: 32123047

Full text available

9
Retinal Optical Coherence Tomography in Neuromyelitis Optica
Material Type:
Article
Add to My Research

Retinal Optical Coherence Tomography in Neuromyelitis Optica

Neurology : neuroimmunology & neuroinflammation, 2021-11, Vol.8 (6) [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000001068 ;PMID: 34526385

Full text available

10
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD
Material Type:
Article
Add to My Research

Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD

Neurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1) [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2022 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200065 ;PMID: 36446614

Full text available

11
Arterial Spin Labeling Changes Parallel Asymmetric Perisylvian and Perirolandic Symptoms in 3 Pediatric Cases of Anti-NMDAR Encephalitis
Material Type:
Article
Add to My Research

Arterial Spin Labeling Changes Parallel Asymmetric Perisylvian and Perirolandic Symptoms in 3 Pediatric Cases of Anti-NMDAR Encephalitis

Neurology : neuroimmunology & neuroinflammation, 2023-07, Vol.10 (4) [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200119 ;PMID: 37094999

Full text available

12
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
Material Type:
Article
Add to My Research

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis

Neurology : neuroimmunology & neuroinflammation, 2021-05, Vol.8 (3) [Peer Reviewed Journal]

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000000974 ;PMID: 33848259

Full text available

13
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis
Material Type:
Article
Add to My Research

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2024-05, Vol.11 (3), p.e200231-e200231 [Peer Reviewed Journal]

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200231 ;PMID: 38626360

Full text available

14
Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19
Material Type:
Article
Add to My Research

Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19

Neurology : neuroimmunology & neuroinflammation, 2024-05, Vol.11 (3), p.e200244-e200244 [Peer Reviewed Journal]

EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200244 ;PMID: 38630952

Full text available

15
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis
Material Type:
Article
Add to My Research

Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis

Neurology : neuroimmunology & neuroinflammation, 2023-07, Vol.10 (4) [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200108 ;PMID: 37147137

Full text available

16
Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis
Material Type:
Article
Add to My Research

Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis

Neurology : neuroimmunology & neuroinflammation, 2022-05, Vol.9 (3) [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000001147 ;PMID: 35217580

Full text available

17
Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation
Material Type:
Article
Add to My Research

Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation

Neurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200196-e200196 [Peer Reviewed Journal]

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200196 ;PMID: 38181319

Full text available

18
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis
Material Type:
Article
Add to My Research

Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200202-e200202 [Peer Reviewed Journal]

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200202 ;PMID: 38346268

Full text available

19
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies
Material Type:
Article
Add to My Research

Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies

Neurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1) [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2022 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200064 ;PMID: 36414428

Full text available

20
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception
Material Type:
Article
Add to My Research

Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception

Neurology : neuroimmunology & neuroinflammation, 2023-09, Vol.10 (5) [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200161 ;PMID: 37550074

Full text available

Results 1 - 20 of 72  for All Library Resources

Results 1 2 3 4 next page

Searching Remote Databases, Please Wait